These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35704604)

  • 1. Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study.
    de Andrade Pereira Silva M; Ribeiro HF; Oliveira RR; Pelloso FC; Pujals C; Pedroso RB; Carvalho MDB; Pelloso SM
    PLoS One; 2022; 17(6):e0269091. PubMed ID: 35704604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic and epidemiological characteristics of pregnant and postpartum women who died from severe acute respiratory syndrome in Brazil: A retrospective cohort study comparing COVID-19 and nonspecific etiologic causes.
    Franco VF; Rodrigues AS; Junior ERR; de Godói LG; Monroy NAJ; da Costa RA; Francisco RPV
    PLoS One; 2022; 17(10):e0274797. PubMed ID: 36191001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of pregnant women with SARS-CoV-2 infection and other severe acute respiratory infections (SARI) in Brazil from January to November 2020.
    Leal LF; Merckx J; Fell DB; Kuchenbecker R; Miranda AE; de Oliveira WK; Platt RW; Antunes L; Silveira MF; Barbieri NB
    Braz J Infect Dis; 2021; 25(5):101620. PubMed ID: 34563490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease.
    Testa CB; de Godoi LG; Monroy NAJ; Bortolotto MRFL; Rodrigues AS; Francisco RPV
    Clinics (Sao Paulo); 2024; 79():100454. PubMed ID: 39121513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, epidemiological characteristics and mortality of pregnant and postpartum women associated with COVID-19 in Brazil: cohort study.
    Dos Santos GG; da Silva ALC; do Nascimento ES; de Andrade LH
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38994462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
    Kalafat E; Prasad S; Birol P; Tekin AB; Kunt A; Di Fabrizio C; Alatas C; Celik E; Bagci H; Binder J; Le Doare K; Magee LA; Mutlu MA; Yassa M; Tug N; Sahin O; Krokos P; O'brien P; von Dadelszen P; Palmrich P; Papaioannou G; Ayaz R; Ladhani SN; Kalantaridou S; Mihmanli V; Khalil A
    Am J Obstet Gynecol; 2022 Mar; 226(3):403.e1-403.e13. PubMed ID: 34582796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal mortality associated with COVID-19 in Brazil in 2020 and 2021: Comparison with non-pregnant women and men.
    Gonçalves BMM; Franco RPV; Rodrigues AS
    PLoS One; 2021; 16(12):e0261492. PubMed ID: 34932589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.
    Prabhu M; Cagino K; Matthews KC; Friedlander RL; Glynn SM; Kubiak JM; Yang YJ; Zhao Z; Baergen RN; DiPace JI; Razavi AS; Skupski DW; Snyder JR; Singh HK; Kalish RB; Oxford CM; Riley LE
    BJOG; 2020 Nov; 127(12):1548-1556. PubMed ID: 32633022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: a nationwide population-based cohort study.
    Siqueira TS; de Souza EKG; Martins-Filho PR; Silva JRS; Gurgel RQ; Cuevas LE; Santos VS
    J Travel Med; 2022 May; 29(3):. PubMed ID: 34983057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil.
    Menezes MO; Takemoto MLS; Nakamura-Pereira M; Katz L; Amorim MMR; Salgado HO; Melo A; Diniz CSG; de Sousa LAR; Magalhaes CG; Knobel R; Andreucci CB;
    Int J Gynaecol Obstet; 2020 Dec; 151(3):415-423. PubMed ID: 33011966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Covid-19 in pregnant and postpartum women admitted to an intensive care unit: A retrospective cohort study.
    Melo Mendes IC; Martins de Oliveira AL; Martins Pinheiro Trindade P; Mendes da Silva W; Pontes Frankel P; Carvalho Mocarzel C; de Alencar Rosa M; Santos Nascimento AP; de Melo Rodrigues G; Pimentel C; de Moraes Perlingeiro R; Gonçalves Lisbôa Pereira A; Caminha Escosteguy C; Mello Galliez R
    PLoS One; 2023; 18(12):e0295444. PubMed ID: 38096234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination effects on reducing COVID-19 complications in pregnancy: A large-scale report from Iran.
    Changizi N; Eshrati B; Salehi M; Beheshtian M; Hadipour Jahromy L; Emami Afshar N; Hejazi S; Hantoushzadeh S; Eslamian L; Savaie M; Raeisi A; Pooransari P
    Int J Gynaecol Obstet; 2023 Dec; 163(3):1012-1017. PubMed ID: 37655467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].
    Huré M; Peyronnet V; Sibiude J; Cazenave MG; Anselem O; Luton D; Vauloup-Fellous C; Deruelle P; Cordier AG; Benachi A; Mandelbrot L; Couffignal C; Pauphilet V; Vivanti AJ; Picone O
    Gynecol Obstet Fertil Senol; 2022 Nov; 50(11):712-720. PubMed ID: 35914734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants.
    Eid J; Abdelwahab M; Williams H; Caplan M; Hajmurad S; Venkatesh KK; Costantine MM; Rood KM
    Am J Reprod Immunol; 2022 Sep; 88(3):e13596. PubMed ID: 35789021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.
    Butt AA; Chemaitelly H; Al Khal A; Coyle PV; Saleh H; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are in-hospital COVID-19-related mortality and morbidity in pregnancy associated with gestational age?
    Leung C; Simões E Silva AC; Oliveira EA
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):234-242. PubMed ID: 35502537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19.
    Barbero P; Mugüerza L; Herraiz I; García Burguillo A; San Juan R; Forcén L; Mejía I; Batllori E; Montañez MD; Vallejo P; Villar O; García Alcazar D; Galindo A
    J Matern Fetal Neonatal Med; 2022 Jul; 35(14):2648-2654. PubMed ID: 32689846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.